A mathematical model to investigate drug targets for dupilumab poor responders in atopic dermatitis

被引：0
|
作者：
Miyano, T. [1 ]
Irvine, A. D. [2 ,3 ]
Tanaka, R. J. [1 ]
机构：
[1] Imperial Coll London, London, England
[2] Trinity Coll Dublin, Med Clin, Dublin, Ireland
[3] Childrens Hlth Ireland, Pediat Dermatol, Dublin, Ireland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P61
引用
下载
收藏
页码：E39 / E40
页数：2
相关论文
共 50 条
  • [31] Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: single-center, retrospective study
    Seul, Tae Woong
    Park, Hyun Woo
    Kim, Hyo Yoon
    Shin, Jung Jin
    Son, Sang Wook
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [32] On the relevance of an in vitro reconstructed human epidermis model for drug screening in atopic dermatitis
    Hubaux, Roland
    Bastin, Coralie
    Salmon, Michel
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (12) : 1403 - 1407
  • [33] Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
    Georgakopoulos, Jorge R.
    Felfeli, Tina
    Drucker, Aaron M.
    Jo, Christine E.
    Piguet, Vincent
    Yeung, Jensen
    JAAD INTERNATIONAL, 2021, 4 : 67 - 69
  • [34] Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation
    Murota, Hiroyuki
    Takeuchi, Satoshi
    Sugaya, Makoto
    Tanioka, Miki
    Onozuka, Daisuke
    Hagihara, Akihito
    Saekif, Hidehisa.
    Imafuku, Shinichi
    Abeh, Masatoshi
    Shintani, Yoichi
    Kaneko, Sakae
    Masuda, Koji
    Hiragun, Takaaki
    Inomata, Naoko
    Kitami, Yuki
    Tsunemi, Yuichiro
    Abe, Shinya
    Kobayashi, Miwa
    Morisky, Donald E.
    Furue, Masutaka
    Katoh, Norihito
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, 79 (03) : 279 - 287
  • [35] Causal relationship between circulating plasma lipids and atopic dermatitis risk: potential drug targets and therapeutic strategies
    Ao He
    Zhisheng Hong
    Zhaoyi Jing
    Haoteng Ma
    Hainan Li
    Archives of Dermatological Research, 317 (1)
  • [36] AN IN VITRO IMMUNOCOMPETENT HUMAN TISSUE-ENGINEERED MODEL OF ATOPIC DERMATITIS FOR DRUG TESTING
    Vazquez, Inmaculada Barragan
    Danby, Simon
    Garcia Gonzalez, Vicente Marco
    Lopez Almagro, Rosa
    Crespo Crespo, Maria Isabel
    Colley, Helen
    Murdoch, Craig
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 492 - 492
  • [37] A COMPUTATIONAL MODEL TO INVESTIGATE DRUG TARGETS IN AD PATIENTS WITH HETEROGENOUS RESPONSE TO BIOLOGIC DRUGS
    Miyano, Takuya
    Irvine, Alan D.
    Tanaka, Reiko J.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 45 - 45
  • [38] DRUG SURVIVAL ANALYSIS OF DUPILUMAB AND ASSOCIATED PREDICTORS IN PATIENTS WITH ATOPIC DERMATITIS IN SOUTH KOREA: 4 YEARS, SINGLE-CENTER, RETROSPECTIVE STUDY
    Seul, Tae Woong
    Park, Hyun Woo
    Kim, Hyo Yoon
    Shin, Jung Jin
    Son, Sang Wook
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 23 - 23
  • [39] Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: 4 year, single-center, retrospective study
    Shin, J. J.
    Seul, T. W.
    Park, H. W.
    Kim, H. Y.
    Son, S. W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S354 - S354
  • [40] Quantifying Inflammatory Response and Drug- Aided Resolution in an Atopic Dermatitis Model with Deep Learning
    Greenfield, Daniel A.
    Feizpour, Amin
    Evans, Conor L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (08) : 1430 - 1438.e4
12345